^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Tissue Of Origin Test Kit - FFPE

Company:
Vyant Bio
Type:
FDA Approved
Evidence Level:
Sensitive: C4 – Case Studies

[FGFR2-POC1B fusion-Cholangiocarcinoma-pemigatinib]

Title:
Durable response from fibroblast growth factor receptor inhibition in intrahepatic cholangiocarcinoma terminated by metachronous acute myeloid leukemia: a case report
Published date:
12/15/2023
Excerpt:
A 69-year-old Caucasian patient...the diagnosis of intrahepatic cholangiocarcinoma, with differentiation grade G2, was confirmed. Since it was an R0 resection of stage I tumor... DNA extraction from Maxwell® RSC DNA FFPE Kit (Promega), DNA amplification through polymerase chain reaction and analysis through capillary electrophoresis (GenomeLab GeXP of Beckman Coulter), which identified an FGFR2 translocation/fusion (FGFR2-POC1B). A targeted therapy with pemigatinib...Our patient had a durable stable disease...
DOI:
10.1186/s13256-023-04231-2